Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
暂无分享,去创建一个
T. Renné | W. Gahl | Stefan Schmidbauer | F. Mueller | Stephanie A. Smith | N. Mutch | J. Morrissey | W. Schenk | H. Spronk | Lucie Esterl
[1] Beppie van den Bogaerde,et al. Clinical practice , 2011, European Journal of Pediatrics.
[2] Arthur Kornberg,et al. Inorganic polyphosphate: essential for growth and survival. , 2009, Annual review of biochemistry.
[3] O. McCarty,et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. , 2009, Blood.
[4] M. Ponczek,et al. Evolution of the contact phase of vertebrate blood coagulation , 2008, Journal of thrombosis and haemostasis : JTH.
[5] J. Morrissey,et al. Polyphosphate as a general procoagulant agent , 2008, Journal of thrombosis and haemostasis : JTH.
[6] B. Zuraw. Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.
[7] C. Maas,et al. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. , 2008, The Journal of clinical investigation.
[8] A. Schmaier. The elusive physiologic role of Factor XII. , 2008, The Journal of clinical investigation.
[9] T. Renné,et al. Novel roles for factor XII-driven plasma contact activation system , 2008, Current opinion in hematology.
[10] B. Furie,et al. Mechanisms of thrombus formation. , 2008, The New England journal of medicine.
[11] D. Wagner,et al. The vessel wall and its interactions. , 2008, Blood.
[12] D. Tanné,et al. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. , 2008, Blood.
[13] N. Mackman. Triggers, targets and treatments for thrombosis , 2008, Nature.
[14] T. Renné,et al. Intrinsic Pathway of Coagulation and Arterial Thrombosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[15] James H Morrissey,et al. Polyphosphate enhances fibrin clot structure. , 2007, Blood.
[16] James H Morrissey,et al. Sensitive fluorescence detection of polyphosphate in polyacrylamide gels using 4′,6‐diamidino‐2‐phenylindol , 2007, Electrophoresis.
[17] T. Renné,et al. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? , 2007, Journal of thrombosis and haemostasis : JTH.
[18] B. Jilma,et al. Evidence of a U‐shaped association between factor XII activity and overall survival , 2007, Journal of thrombosis and haemostasis : JTH.
[19] K. Preissner,et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation , 2007, Proceedings of the National Academy of Sciences.
[20] C. Weber,et al. Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease , 2007, Circulation research.
[21] D. Seiffert,et al. Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice , 2006, Journal of thrombosis and haemostasis : JTH.
[22] T. Renné,et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.
[23] James H Morrissey,et al. Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Renné,et al. Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.
[25] 大房 健. 基礎講座 電気泳動(Electrophoresis) , 2005 .
[26] Hui Zhang,et al. Platelet activation leads to activation and propagation of the complement system , 2005, The Journal of experimental medicine.
[27] F. Marceau,et al. International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences , 2005, Pharmacological Reviews.
[28] E. Oldfield,et al. Human Platelet Dense Granules Contain Polyphosphate and Are Similar to Acidocalcisomes of Bacteria and Unicellular Eukaryotes* , 2004, Journal of Biological Chemistry.
[29] T. Renné,et al. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo , 2004, Thrombosis and Haemostasis.
[30] Zaverio M. Ruggeri,et al. Platelets in atherothrombosis , 2002, Nature Medicine.
[31] A. Davis,et al. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.
[32] E. Kuehl,et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). , 1998, The New England journal of medicine.
[33] L. Björck,et al. Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases , 1998, Nature Medicine.
[34] A. Kornberg,et al. Inorganic Polyphosphate in Mammalian Cells and Tissues (*) , 1995, The Journal of Biological Chemistry.
[35] M. Silverberg,et al. Activation of the classical pathway of complement by Hageman factor fragment , 1981, The Journal of experimental medicine.
[36] A. Mangal,et al. HAGEMAN FACTOR DEFICIENCY AND ORAL CONTRACEPTIVES , 1980, The Lancet.
[37] R. Sheon,et al. The Demise of John Hageman , 1968 .
[38] J. Caen,et al. Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia , 1965, Nature.
[39] O. Ratnoff,et al. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.
[40] G. Glaeske,et al. Ambulante Hämophilie-Behandlung im Krankenhaus – Aktueller Stand der gesetzlichen Grundlagen für Versorgungsverträge , 2009 .
[41] T. Renné,et al. Local Bradykinin Formation Is Controlled by Glycosaminoglycans , 2005 .
[42] J. Griffin,et al. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. , 1981, Blood.